Medicine and Dentistry
Canakinumab
12%
Cancer Growth
12%
Cancer Pathobiology
12%
Cancer Therapy
12%
Cell Population
12%
Clear Cell Renal Cell Carcinoma
100%
Clinical Trial
50%
Clinical Trial Design
12%
Immune Response
12%
Immune System
75%
Immunity
100%
Immunology
12%
Immunosuppressive Drug
12%
Immunotherapy
62%
Interleukin 1beta
100%
Kidney Cancer
100%
Kidney Tumour
37%
Macrophage
12%
Metastatic Kidney Cancer
12%
Neoadjuvant Therapy
12%
Neoplasm
62%
Organoid
12%
Recurrent Disease
25%
Spartalizumab
12%
Systemic Therapy
12%
Treatment Response
12%
Tumor Biology
12%
Tumor Cell
12%
Pharmacology, Toxicology and Pharmaceutical Science
Canakinumab
11%
Cancer Growth
11%
Clinical Trial
44%
Clinical Trial Design
11%
Drug Development
11%
Immunosuppressive Agent
11%
Immunotherapy
55%
Interleukin 1beta
100%
Kidney Cancer
100%
Kidney Tumour
33%
Malignant Neoplasm
11%
Mouse
11%
Neoplasm
77%
Recurrent Disease
22%
Remission
11%
Renal Cell Carcinoma
100%
Spartalizumab
11%